CONFERENCE COVERAGE
Psych Congress
Annual Meeting
2022 COVERAGE
- Psilocybin Improves Depression Symptoms in Treatment-Resistant Depression
- In Bipolar Disorder, Lumateperone Improves Function, Quality of Life
- Clinicians Interact With Prescription Digital Therapeutic for Opioid Use Disorder
- Attention-Deficit Hyperactivity Disorder Severity Reduced With SDX/d-MPH
- Clinicians Have Knowledge Gaps About Long-Acting Injectable Antipsychotic Agents
- Dextromethorphan-Bupropion Effective for Comorbid Anxiety, Major Depressive Disorder
- Xanomeline-Trospium Improves PANSS Scores for Patients With Schizophrenia
- Viloxazine Plus Caffeine Increases Insomnia Likelihood in Adults With ADHD
- Anticholinergics Not Recommended for Treating Tardive Dyskinesia
- Assessing Depression With Patient Health Questionnaire Over Time Improves Care
- Potential Solriamfetol Wake Promotion Mechanisms Shown in Preclinical Trial
- Pharmacogenomic Testing May Improve Psychiatric Care Treatment Strategies
Latest Tweets
Follow
@PsychCongress
Conference Coverage from
